Spl Image 1 Structural Formula (Spl Image1 Structure)
Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 70511-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70511-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Maia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl Image 2 100 Mcg Vial Label (Spl Image2 Vial 100mcg)
Spl Image 3 200 Mcg Vial Label (Spl Image3 Vial 200mcg)
This appears to be a pharmaceutical description for Levothyroxine Sodium for injection, containing 200 mcg in a single-use vial for intravenous use. The product is marked for prescription-only use, and there are specific instructions to discard any unused portions. There is no information available regarding its indications or side effects.*
Spl Image 4 500 Mcg Vial Label (Spl Image4 Vial 500mcg)
This is a medical label for Levothyroxine Sodium, a prescription medication given through intravenous use. The label shows a single-use vial with a concentration of 500 mcg/vial, with a prescription-only indication.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
